News & Updates
Filter by Specialty:
Smoking cessation, preventing obesity help reduce psoriasis risk
The incidence of psoriasis may be decreased by maintaining a normal weight and by putting a stop to the use of tobacco and cigarettes, a recent study has shown. In addition, addressing the inequality in education may help lower the cases of this condition.
Smoking cessation, preventing obesity help reduce psoriasis risk
11 Mar 2023
Outpatient oritavancin bests inpatient SoC in acute uncomplicated cellulitis
Outpatient oritavancin therapy appears to be more effective than inpatient standard-of-care (SoC) in reducing 30-day hospital readmissions or admissions among individuals with acute uncomplicated cellulitis, a recent study has shown.
Outpatient oritavancin bests inpatient SoC in acute uncomplicated cellulitis
15 Feb 2023
Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
Treatment with dupilumab helps improve the signs and symptoms of erythrodermic atopic dermatitis, with the improvements occurring as early as the first week and being sustained over time, according to a study. The drug has an acceptable safety profile.
Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
04 Feb 2023
Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo
Treatment with oral ritlecitinib improves outcomes in patients with active nonsegmental vitiligo, without any serious adverse events over 48 weeks, results of a study have shown.
Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo
27 Jan 2023
Online on par with in-person care for improving outcomes in psoriasis
An online health model appears to be as effective as in-person care for decreasing functional impairment and depressive symptoms in patients with psoriasis, according to a study.
Online on par with in-person care for improving outcomes in psoriasis
26 Jan 2023
Multiple moles, genetic predisposition up risk of second primary melanomas
Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.
Multiple moles, genetic predisposition up risk of second primary melanomas
22 Jan 2023
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.
